Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease
Pharmacogenomics · 2023
DOI: 10.2217/pgs-2022-0137 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacogenomics, 2023. Verfasst von Ramón Cacabelos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, International Center of Neuroscience & Genomic Medicine, EuroEspes Biomedical Research Center, Bergondo, Corunna, 151…. Hauptthemen laut MEDLINE: Alzheimer Disease, Arylamine N-Acetyltransferase. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Themen: Depression, Demenz
Abstract (Originalsprache)
Anxiety and depression coexist with cognitive impairment in Alzheimer's disease along with other concomitant disorders (>60%), which require multipurpose treatments. Polypharmaceutical regimens cause drug-drug interactions and adverse drug reactions, potentially avoidable in number and severity with the implementation of pharmacogenetic procedures. The accumulation of defective variants (>30 genes per patient in more than 50% of cases) in pharmagenes (pathogenic, mechanistic, metabolic, transporter, pleiotropic) influences the therapeutic response to antidementia, antidepressant and anxiolytic drugs in polyvalent regimens. APOE, CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4, CYP3A5, CYP4F2, COMT, MAOB, CHAT, GSTP1, NAT2, SLC30A8, SLCO1B1, ADRA2A, ADRB2, BCHE, GABRA1, HMGCR, HTR2C, IFNL3, NBEA, UGT1A1, ABCB1, ABCC2, ABCG2, SLC6A2, SLC6A3, SLC6A4, MTHFR and OPRM1 variants affect anxiety and depression in Alzheimer's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomic Medicine, International Center of Neuroscience & Genomic Medicine, EuroEspes Biomedical Research Center, Bergondo, Corunna, 15165, Spain.
- Department of Genomics & Pharmacogenomics, International Center of Neuroscience & Genomic Medicine, EuroEspes Biomedical Research Center, Bergondo, Corunna, 15165, Spain.
- Department of Medical Biochemistry, International Center of Neuroscience & Genomic Medicine, EuroEspes Biomedical Research Center, Bergondo, Corunna, 15165, Spain.
- Department of Neuropsychology, International Center of Neuroscience & Genomic Medicine, EuroEspes Biomedical Research Center, Bergondo, Corunna, 15165, Spain.
- Department of Medical Documentation, International Center of Neuroscience & Genomic Medicine, EuroEspes Biomedical Research Center, Bergondo, Corunna, 15165, Spain.
- Department of Nursing, International Center of Neuroscience & Genomic Medicine, EuroEspes Biomedical Research Center, Bergondo, Corunna, 15165, Spain.
ORCID-Profile: Ramón Cacabelos, Juan C Carril
Zitieren
APA
Cacabelos, R., Carril, J. C., Corzo, L., Pego, R., Cacabelos, N., Alcaraz, M., Muñiz, A., Martínez-Iglesias, O., & Naidoo, V. (2023). Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease. Pharmacogenomics. https://doi.org/10.2217/pgs-2022-0137
Vancouver
Cacabelos R, Carril JC, Corzo L, Pego R, Cacabelos N, Alcaraz M, et al. Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease. Pharmacogenomics. 2023. doi:10.2217/pgs-2022-0137
BibTeX
@article{Cacabelos2023,
author = {Cacabelos, Ramón and Carril, Juan C and Corzo, Lola and Pego, Rocío and Cacabelos, Natalia and Alcaraz, Margarita and Muñiz, Adriana and Martínez-Iglesias, Olaia and Naidoo, Vinogran},
title = {Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease},
journal = {Pharmacogenomics},
year = {2023},
doi = {10.2217/pgs-2022-0137}
}
EUVIMED